nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—CYP2C8—Ifosfamide—testicular cancer	0.103	0.204	CbGbCtD
Thioridazine—ADRA1B—vas deferens—testicular cancer	0.0879	0.404	CbGeAlD
Thioridazine—CYP2C19—Ifosfamide—testicular cancer	0.0864	0.171	CbGbCtD
Thioridazine—CYP2C9—Ifosfamide—testicular cancer	0.0718	0.142	CbGbCtD
Thioridazine—CYP2E1—Etoposide—testicular cancer	0.0659	0.13	CbGbCtD
Thioridazine—HTR7—vas deferens—testicular cancer	0.0512	0.236	CbGeAlD
Thioridazine—CYP2C8—Etoposide—testicular cancer	0.0492	0.0974	CbGbCtD
Thioridazine—CYP1A2—Etoposide—testicular cancer	0.0381	0.0754	CbGbCtD
Thioridazine—CYP2C9—Cisplatin—testicular cancer	0.0349	0.0691	CbGbCtD
Thioridazine—CYP2D6—Vinblastine—testicular cancer	0.0348	0.0689	CbGbCtD
Thioridazine—HTR7—vein—testicular cancer	0.0217	0.1	CbGeAlD
Thioridazine—CYP2D6—Doxorubicin—testicular cancer	0.0214	0.0424	CbGbCtD
Thioridazine—HTR2A—vein—testicular cancer	0.0136	0.0624	CbGeAlD
Thioridazine—KCNH2—seminal vesicle—testicular cancer	0.0036	0.0166	CbGeAlD
Thioridazine—ADRA2A—seminal vesicle—testicular cancer	0.00283	0.013	CbGeAlD
Thioridazine—HTR7—gonad—testicular cancer	0.00279	0.0129	CbGeAlD
Thioridazine—CYP2E1—seminal vesicle—testicular cancer	0.00277	0.0128	CbGeAlD
Thioridazine—HTR2A—embryo—testicular cancer	0.00257	0.0118	CbGeAlD
Thioridazine—KCNH2—female gonad—testicular cancer	0.00211	0.00973	CbGeAlD
Thioridazine—ADRA2A—gonad—testicular cancer	0.00205	0.00943	CbGeAlD
Thioridazine—HTR7—testis—testicular cancer	0.00201	0.00927	CbGeAlD
Thioridazine—DRD2—testis—testicular cancer	0.0019	0.00876	CbGeAlD
Thioridazine—KCNH2—testis—testicular cancer	0.00188	0.00863	CbGeAlD
Thioridazine—HTR2A—gonad—testicular cancer	0.00174	0.00802	CbGeAlD
Thioridazine—CYP2C8—testis—testicular cancer	0.00172	0.0079	CbGeAlD
Thioridazine—HRH1—female gonad—testicular cancer	0.00169	0.0078	CbGeAlD
Thioridazine—ADRA2A—female gonad—testicular cancer	0.00166	0.00766	CbGeAlD
Thioridazine—HRH1—testis—testicular cancer	0.0015	0.00692	CbGeAlD
Thioridazine—ADRA2A—testis—testicular cancer	0.00148	0.0068	CbGeAlD
Thioridazine—CYP2E1—testis—testicular cancer	0.00144	0.00665	CbGeAlD
Thioridazine—Agranulocytosis—Dactinomycin—testicular cancer	0.00144	0.00518	CcSEcCtD
Thioridazine—Anaemia—Vinblastine—testicular cancer	0.00141	0.00509	CcSEcCtD
Thioridazine—Ventricular arrhythmia—Doxorubicin—testicular cancer	0.0014	0.00503	CcSEcCtD
Thioridazine—Cardiac arrest—Etoposide—testicular cancer	0.00137	0.00496	CcSEcCtD
Thioridazine—Confusional state—Chlorambucil—testicular cancer	0.00137	0.00495	CcSEcCtD
Thioridazine—Leukopenia—Vinblastine—testicular cancer	0.00137	0.00493	CcSEcCtD
Thioridazine—KCNH2—lymph node—testicular cancer	0.00136	0.00626	CbGeAlD
Thioridazine—Blood disorder—Epirubicin—testicular cancer	0.00134	0.00482	CcSEcCtD
Thioridazine—Thrombocytopenia—Chlorambucil—testicular cancer	0.00133	0.0048	CcSEcCtD
Thioridazine—Sweating increased—Cisplatin—testicular cancer	0.00133	0.00479	CcSEcCtD
Thioridazine—Agranulocytosis—Ifosfamide—testicular cancer	0.00132	0.00475	CcSEcCtD
Thioridazine—Anorexia—Chlorambucil—testicular cancer	0.0013	0.00468	CcSEcCtD
Thioridazine—Pancytopenia—Cisplatin—testicular cancer	0.0013	0.00467	CcSEcCtD
Thioridazine—Erythema—Bleomycin—testicular cancer	0.00129	0.00465	CcSEcCtD
Thioridazine—CYP2D6—female gonad—testicular cancer	0.00129	0.00593	CbGeAlD
Thioridazine—Amenorrhoea—Epirubicin—testicular cancer	0.00127	0.00458	CcSEcCtD
Thioridazine—HTR2A—testis—testicular cancer	0.00126	0.00578	CbGeAlD
Thioridazine—Blood disorder—Doxorubicin—testicular cancer	0.00124	0.00446	CcSEcCtD
Thioridazine—Thrombocytopenia—Vinblastine—testicular cancer	0.00122	0.0044	CcSEcCtD
Thioridazine—Sweating increased—Etoposide—testicular cancer	0.00122	0.00439	CcSEcCtD
Thioridazine—Erythema—Dactinomycin—testicular cancer	0.0012	0.00434	CcSEcCtD
Thioridazine—Anaemia—Bleomycin—testicular cancer	0.00119	0.0043	CcSEcCtD
Thioridazine—Anorexia—Vinblastine—testicular cancer	0.00119	0.00429	CcSEcCtD
Thioridazine—Pancytopenia—Etoposide—testicular cancer	0.00119	0.00428	CcSEcCtD
Thioridazine—Decreased appetite—Chlorambucil—testicular cancer	0.00118	0.00426	CcSEcCtD
Thioridazine—Amenorrhoea—Doxorubicin—testicular cancer	0.00118	0.00424	CcSEcCtD
Thioridazine—Leukopenia—Bleomycin—testicular cancer	0.00115	0.00416	CcSEcCtD
Thioridazine—CYP2D6—testis—testicular cancer	0.00114	0.00526	CbGeAlD
Thioridazine—Arrhythmia—Ifosfamide—testicular cancer	0.00113	0.00408	CcSEcCtD
Thioridazine—Feeling abnormal—Chlorambucil—testicular cancer	0.00112	0.00404	CcSEcCtD
Thioridazine—Aplastic anaemia—Methotrexate—testicular cancer	0.00112	0.00404	CcSEcCtD
Thioridazine—Ventricular tachycardia—Epirubicin—testicular cancer	0.00112	0.00403	CcSEcCtD
Thioridazine—Anaemia—Dactinomycin—testicular cancer	0.00111	0.00401	CcSEcCtD
Thioridazine—Mental disorder—Ifosfamide—testicular cancer	0.00111	0.004	CcSEcCtD
Thioridazine—Abnormal dreams—Epirubicin—testicular cancer	0.0011	0.00398	CcSEcCtD
Thioridazine—Dermatitis contact—Epirubicin—testicular cancer	0.0011	0.00398	CcSEcCtD
Thioridazine—Erythema—Ifosfamide—testicular cancer	0.0011	0.00398	CcSEcCtD
Thioridazine—HRH1—lymph node—testicular cancer	0.00109	0.00501	CbGeAlD
Thioridazine—Jaundice—Etoposide—testicular cancer	0.00109	0.00392	CcSEcCtD
Thioridazine—Decreased appetite—Vinblastine—testicular cancer	0.00108	0.00391	CcSEcCtD
Thioridazine—Leukopenia—Dactinomycin—testicular cancer	0.00108	0.00388	CcSEcCtD
Thioridazine—Body temperature increased—Chlorambucil—testicular cancer	0.00108	0.00388	CcSEcCtD
Thioridazine—ADRA2A—lymph node—testicular cancer	0.00107	0.00493	CbGeAlD
Thioridazine—Gynaecomastia—Methotrexate—testicular cancer	0.00107	0.00385	CcSEcCtD
Thioridazine—Constipation—Vinblastine—testicular cancer	0.00107	0.00384	CcSEcCtD
Thioridazine—Confusional state—Bleomycin—testicular cancer	0.00106	0.00383	CcSEcCtD
Thioridazine—Oedema—Bleomycin—testicular cancer	0.00105	0.0038	CcSEcCtD
Thioridazine—Aplastic anaemia—Epirubicin—testicular cancer	0.00105	0.00378	CcSEcCtD
Thioridazine—Agranulocytosis—Etoposide—testicular cancer	0.00104	0.00375	CcSEcCtD
Thioridazine—Vision blurred—Ifosfamide—testicular cancer	0.00104	0.00375	CcSEcCtD
Thioridazine—Ventricular tachycardia—Doxorubicin—testicular cancer	0.00103	0.00373	CcSEcCtD
Thioridazine—Thrombocytopenia—Bleomycin—testicular cancer	0.00103	0.00372	CcSEcCtD
Thioridazine—Feeling abnormal—Vinblastine—testicular cancer	0.00103	0.0037	CcSEcCtD
Thioridazine—Abnormal dreams—Doxorubicin—testicular cancer	0.00102	0.00368	CcSEcCtD
Thioridazine—Dermatitis contact—Doxorubicin—testicular cancer	0.00102	0.00368	CcSEcCtD
Thioridazine—Anaemia—Ifosfamide—testicular cancer	0.00102	0.00367	CcSEcCtD
Thioridazine—Agitation—Ifosfamide—testicular cancer	0.00101	0.00365	CcSEcCtD
Thioridazine—Angioedema—Ifosfamide—testicular cancer	0.00101	0.00363	CcSEcCtD
Thioridazine—Anorexia—Bleomycin—testicular cancer	0.001	0.00362	CcSEcCtD
Thioridazine—Hypersensitivity—Chlorambucil—testicular cancer	0.001	0.00361	CcSEcCtD
Thioridazine—Leukopenia—Ifosfamide—testicular cancer	0.000987	0.00356	CcSEcCtD
Thioridazine—Photosensitivity—Methotrexate—testicular cancer	0.000986	0.00356	CcSEcCtD
Thioridazine—Hypotension—Bleomycin—testicular cancer	0.000984	0.00355	CcSEcCtD
Thioridazine—Oedema—Dactinomycin—testicular cancer	0.000982	0.00354	CcSEcCtD
Thioridazine—Arrhythmia—Cisplatin—testicular cancer	0.000975	0.00352	CcSEcCtD
Thioridazine—Aplastic anaemia—Doxorubicin—testicular cancer	0.00097	0.0035	CcSEcCtD
Thioridazine—Thrombocytopenia—Dactinomycin—testicular cancer	0.000961	0.00347	CcSEcCtD
Thioridazine—Erythema—Cisplatin—testicular cancer	0.00095	0.00343	CcSEcCtD
Thioridazine—Anorexia—Dactinomycin—testicular cancer	0.000936	0.00338	CcSEcCtD
Thioridazine—Diarrhoea—Chlorambucil—testicular cancer	0.000931	0.00336	CcSEcCtD
Thioridazine—Photosensitivity—Epirubicin—testicular cancer	0.000923	0.00333	CcSEcCtD
Thioridazine—Hypersensitivity—Vinblastine—testicular cancer	0.000918	0.00331	CcSEcCtD
Thioridazine—Dermatitis exfoliative—Methotrexate—testicular cancer	0.000918	0.00331	CcSEcCtD
Thioridazine—Decreased appetite—Bleomycin—testicular cancer	0.000915	0.0033	CcSEcCtD
Thioridazine—Confusional state—Ifosfamide—testicular cancer	0.000907	0.00327	CcSEcCtD
Thioridazine—Oedema—Ifosfamide—testicular cancer	0.0009	0.00325	CcSEcCtD
Thioridazine—Vision blurred—Cisplatin—testicular cancer	0.000896	0.00323	CcSEcCtD
Thioridazine—Tremor—Cisplatin—testicular cancer	0.00089	0.00321	CcSEcCtD
Thioridazine—Lethargy—Methotrexate—testicular cancer	0.000884	0.00319	CcSEcCtD
Thioridazine—Thrombocytopenia—Ifosfamide—testicular cancer	0.000881	0.00318	CcSEcCtD
Thioridazine—Anaemia—Cisplatin—testicular cancer	0.000878	0.00317	CcSEcCtD
Thioridazine—Hyperhidrosis—Ifosfamide—testicular cancer	0.00087	0.00314	CcSEcCtD
Thioridazine—Feeling abnormal—Bleomycin—testicular cancer	0.000867	0.00313	CcSEcCtD
Thioridazine—Vomiting—Chlorambucil—testicular cancer	0.000865	0.00312	CcSEcCtD
Thioridazine—Dermatitis exfoliative—Epirubicin—testicular cancer	0.000859	0.0031	CcSEcCtD
Thioridazine—Anorexia—Ifosfamide—testicular cancer	0.000857	0.00309	CcSEcCtD
Thioridazine—Photosensitivity—Doxorubicin—testicular cancer	0.000854	0.00308	CcSEcCtD
Thioridazine—Decreased appetite—Dactinomycin—testicular cancer	0.000853	0.00308	CcSEcCtD
Thioridazine—Diarrhoea—Vinblastine—testicular cancer	0.000853	0.00308	CcSEcCtD
Thioridazine—Leukopenia—Cisplatin—testicular cancer	0.000851	0.00307	CcSEcCtD
Thioridazine—Hypotension—Ifosfamide—testicular cancer	0.000841	0.00303	CcSEcCtD
Thioridazine—Body temperature increased—Bleomycin—testicular cancer	0.000832	0.003	CcSEcCtD
Thioridazine—Lethargy—Epirubicin—testicular cancer	0.000827	0.00298	CcSEcCtD
Thioridazine—Feeling abnormal—Dactinomycin—testicular cancer	0.000809	0.00292	CcSEcCtD
Thioridazine—Nausea—Chlorambucil—testicular cancer	0.000808	0.00291	CcSEcCtD
Thioridazine—Anaemia—Etoposide—testicular cancer	0.000805	0.0029	CcSEcCtD
Thioridazine—Somnolence—Ifosfamide—testicular cancer	0.0008	0.00288	CcSEcCtD
Thioridazine—Dermatitis exfoliative—Doxorubicin—testicular cancer	0.000795	0.00287	CcSEcCtD
Thioridazine—Vomiting—Vinblastine—testicular cancer	0.000792	0.00286	CcSEcCtD
Thioridazine—Decreased appetite—Ifosfamide—testicular cancer	0.000782	0.00282	CcSEcCtD
Thioridazine—Headache—Vinblastine—testicular cancer	0.000781	0.00282	CcSEcCtD
Thioridazine—Leukopenia—Etoposide—testicular cancer	0.000779	0.00281	CcSEcCtD
Thioridazine—Body temperature increased—Dactinomycin—testicular cancer	0.000776	0.0028	CcSEcCtD
Thioridazine—Oedema—Cisplatin—testicular cancer	0.000776	0.0028	CcSEcCtD
Thioridazine—Hypersensitivity—Bleomycin—testicular cancer	0.000775	0.0028	CcSEcCtD
Thioridazine—Cardiac arrest—Epirubicin—testicular cancer	0.000771	0.00278	CcSEcCtD
Thioridazine—Constipation—Ifosfamide—testicular cancer	0.000769	0.00277	CcSEcCtD
Thioridazine—Lethargy—Doxorubicin—testicular cancer	0.000765	0.00276	CcSEcCtD
Thioridazine—Thrombocytopenia—Cisplatin—testicular cancer	0.000759	0.00274	CcSEcCtD
Thioridazine—Tachycardia—Cisplatin—testicular cancer	0.000757	0.00273	CcSEcCtD
Thioridazine—Hyperhidrosis—Cisplatin—testicular cancer	0.00075	0.0027	CcSEcCtD
Thioridazine—Asthma—Methotrexate—testicular cancer	0.000748	0.0027	CcSEcCtD
Thioridazine—Feeling abnormal—Ifosfamide—testicular cancer	0.000741	0.00267	CcSEcCtD
Thioridazine—Eosinophilia—Methotrexate—testicular cancer	0.000741	0.00267	CcSEcCtD
Thioridazine—Nausea—Vinblastine—testicular cancer	0.00074	0.00267	CcSEcCtD
Thioridazine—Anorexia—Cisplatin—testicular cancer	0.000739	0.00267	CcSEcCtD
Thioridazine—Hypotension—Cisplatin—testicular cancer	0.000725	0.00261	CcSEcCtD
Thioridazine—Hypersensitivity—Dactinomycin—testicular cancer	0.000723	0.00261	CcSEcCtD
Thioridazine—Confusional state—Etoposide—testicular cancer	0.000716	0.00258	CcSEcCtD
Thioridazine—Cardiac arrest—Doxorubicin—testicular cancer	0.000713	0.00257	CcSEcCtD
Thioridazine—Body temperature increased—Ifosfamide—testicular cancer	0.000711	0.00257	CcSEcCtD
Thioridazine—Pancytopenia—Methotrexate—testicular cancer	0.000711	0.00256	CcSEcCtD
Thioridazine—Asthma—Epirubicin—testicular cancer	0.0007	0.00253	CcSEcCtD
Thioridazine—Thrombocytopenia—Etoposide—testicular cancer	0.000696	0.00251	CcSEcCtD
Thioridazine—Tachycardia—Etoposide—testicular cancer	0.000693	0.0025	CcSEcCtD
Thioridazine—Eosinophilia—Epirubicin—testicular cancer	0.000693	0.0025	CcSEcCtD
Thioridazine—Hyperhidrosis—Etoposide—testicular cancer	0.000687	0.00248	CcSEcCtD
Thioridazine—Photosensitivity reaction—Methotrexate—testicular cancer	0.000683	0.00246	CcSEcCtD
Thioridazine—Anorexia—Etoposide—testicular cancer	0.000677	0.00244	CcSEcCtD
Thioridazine—Decreased appetite—Cisplatin—testicular cancer	0.000674	0.00243	CcSEcCtD
Thioridazine—Diarrhoea—Dactinomycin—testicular cancer	0.000672	0.00242	CcSEcCtD
Thioridazine—Vomiting—Bleomycin—testicular cancer	0.000669	0.00241	CcSEcCtD
Thioridazine—Drowsiness—Methotrexate—testicular cancer	0.000667	0.00241	CcSEcCtD
Thioridazine—Pancytopenia—Epirubicin—testicular cancer	0.000665	0.0024	CcSEcCtD
Thioridazine—Hypotension—Etoposide—testicular cancer	0.000664	0.00239	CcSEcCtD
Thioridazine—Rash—Bleomycin—testicular cancer	0.000664	0.00239	CcSEcCtD
Thioridazine—Dermatitis—Bleomycin—testicular cancer	0.000663	0.00239	CcSEcCtD
Thioridazine—Hypersensitivity—Ifosfamide—testicular cancer	0.000663	0.00239	CcSEcCtD
Thioridazine—Asthma—Doxorubicin—testicular cancer	0.000648	0.00234	CcSEcCtD
Thioridazine—Eosinophilia—Doxorubicin—testicular cancer	0.000642	0.00231	CcSEcCtD
Thioridazine—Photosensitivity reaction—Epirubicin—testicular cancer	0.000639	0.00231	CcSEcCtD
Thioridazine—Feeling abnormal—Cisplatin—testicular cancer	0.000639	0.00231	CcSEcCtD
Thioridazine—Weight increased—Epirubicin—testicular cancer	0.000637	0.0023	CcSEcCtD
Thioridazine—Somnolence—Etoposide—testicular cancer	0.000632	0.00228	CcSEcCtD
Thioridazine—Nausea—Bleomycin—testicular cancer	0.000625	0.00226	CcSEcCtD
Thioridazine—Drowsiness—Epirubicin—testicular cancer	0.000624	0.00225	CcSEcCtD
Thioridazine—Vomiting—Dactinomycin—testicular cancer	0.000624	0.00225	CcSEcCtD
Thioridazine—Agranulocytosis—Methotrexate—testicular cancer	0.000623	0.00225	CcSEcCtD
Thioridazine—Rash—Dactinomycin—testicular cancer	0.000619	0.00223	CcSEcCtD
Thioridazine—Decreased appetite—Etoposide—testicular cancer	0.000618	0.00223	CcSEcCtD
Thioridazine—Diarrhoea—Ifosfamide—testicular cancer	0.000615	0.00222	CcSEcCtD
Thioridazine—Pancytopenia—Doxorubicin—testicular cancer	0.000615	0.00222	CcSEcCtD
Thioridazine—Body temperature increased—Cisplatin—testicular cancer	0.000613	0.00221	CcSEcCtD
Thioridazine—Jaundice—Epirubicin—testicular cancer	0.000609	0.0022	CcSEcCtD
Thioridazine—Constipation—Etoposide—testicular cancer	0.000608	0.00219	CcSEcCtD
Thioridazine—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000591	0.00213	CcSEcCtD
Thioridazine—Weight increased—Doxorubicin—testicular cancer	0.00059	0.00213	CcSEcCtD
Thioridazine—Feeling abnormal—Etoposide—testicular cancer	0.000585	0.00211	CcSEcCtD
Thioridazine—Nausea—Dactinomycin—testicular cancer	0.000583	0.0021	CcSEcCtD
Thioridazine—Agranulocytosis—Epirubicin—testicular cancer	0.000583	0.0021	CcSEcCtD
Thioridazine—Drowsiness—Doxorubicin—testicular cancer	0.000578	0.00208	CcSEcCtD
Thioridazine—Vomiting—Ifosfamide—testicular cancer	0.000572	0.00206	CcSEcCtD
Thioridazine—Hypersensitivity—Cisplatin—testicular cancer	0.000571	0.00206	CcSEcCtD
Thioridazine—Rash—Ifosfamide—testicular cancer	0.000567	0.00205	CcSEcCtD
Thioridazine—Dermatitis—Ifosfamide—testicular cancer	0.000567	0.00204	CcSEcCtD
Thioridazine—Jaundice—Doxorubicin—testicular cancer	0.000563	0.00203	CcSEcCtD
Thioridazine—Body temperature increased—Etoposide—testicular cancer	0.000562	0.00203	CcSEcCtD
Thioridazine—Oedema peripheral—Epirubicin—testicular cancer	0.000552	0.00199	CcSEcCtD
Thioridazine—Agranulocytosis—Doxorubicin—testicular cancer	0.000539	0.00195	CcSEcCtD
Thioridazine—Nausea—Ifosfamide—testicular cancer	0.000534	0.00193	CcSEcCtD
Thioridazine—Diarrhoea—Cisplatin—testicular cancer	0.000531	0.00191	CcSEcCtD
Thioridazine—Mental disorder—Methotrexate—testicular cancer	0.000525	0.00189	CcSEcCtD
Thioridazine—Hypersensitivity—Etoposide—testicular cancer	0.000523	0.00189	CcSEcCtD
Thioridazine—Erythema—Methotrexate—testicular cancer	0.000521	0.00188	CcSEcCtD
Thioridazine—Oedema peripheral—Doxorubicin—testicular cancer	0.000511	0.00184	CcSEcCtD
Thioridazine—Arrhythmia—Epirubicin—testicular cancer	0.000501	0.00181	CcSEcCtD
Thioridazine—Vomiting—Cisplatin—testicular cancer	0.000493	0.00178	CcSEcCtD
Thioridazine—Vision blurred—Methotrexate—testicular cancer	0.000491	0.00177	CcSEcCtD
Thioridazine—Mental disorder—Epirubicin—testicular cancer	0.000491	0.00177	CcSEcCtD
Thioridazine—Rash—Cisplatin—testicular cancer	0.000489	0.00176	CcSEcCtD
Thioridazine—Dermatitis—Cisplatin—testicular cancer	0.000489	0.00176	CcSEcCtD
Thioridazine—Erythema—Epirubicin—testicular cancer	0.000488	0.00176	CcSEcCtD
Thioridazine—Diarrhoea—Etoposide—testicular cancer	0.000486	0.00175	CcSEcCtD
Thioridazine—Anaemia—Methotrexate—testicular cancer	0.000482	0.00174	CcSEcCtD
Thioridazine—Leukopenia—Methotrexate—testicular cancer	0.000467	0.00168	CcSEcCtD
Thioridazine—Arrhythmia—Doxorubicin—testicular cancer	0.000463	0.00167	CcSEcCtD
Thioridazine—Nausea—Cisplatin—testicular cancer	0.000461	0.00166	CcSEcCtD
Thioridazine—Vision blurred—Epirubicin—testicular cancer	0.00046	0.00166	CcSEcCtD
Thioridazine—Mental disorder—Doxorubicin—testicular cancer	0.000454	0.00164	CcSEcCtD
Thioridazine—Vomiting—Etoposide—testicular cancer	0.000452	0.00163	CcSEcCtD
Thioridazine—Erythema—Doxorubicin—testicular cancer	0.000452	0.00163	CcSEcCtD
Thioridazine—Anaemia—Epirubicin—testicular cancer	0.000451	0.00163	CcSEcCtD
Thioridazine—Agitation—Epirubicin—testicular cancer	0.000448	0.00162	CcSEcCtD
Thioridazine—Rash—Etoposide—testicular cancer	0.000448	0.00162	CcSEcCtD
Thioridazine—Dermatitis—Etoposide—testicular cancer	0.000448	0.00161	CcSEcCtD
Thioridazine—Headache—Etoposide—testicular cancer	0.000445	0.00161	CcSEcCtD
Thioridazine—Leukopenia—Epirubicin—testicular cancer	0.000437	0.00158	CcSEcCtD
Thioridazine—Confusional state—Methotrexate—testicular cancer	0.000429	0.00155	CcSEcCtD
Thioridazine—Vision blurred—Doxorubicin—testicular cancer	0.000426	0.00154	CcSEcCtD
Thioridazine—Nausea—Etoposide—testicular cancer	0.000422	0.00152	CcSEcCtD
Thioridazine—Anaemia—Doxorubicin—testicular cancer	0.000417	0.00151	CcSEcCtD
Thioridazine—Thrombocytopenia—Methotrexate—testicular cancer	0.000417	0.0015	CcSEcCtD
Thioridazine—Agitation—Doxorubicin—testicular cancer	0.000415	0.0015	CcSEcCtD
Thioridazine—Hyperhidrosis—Methotrexate—testicular cancer	0.000411	0.00148	CcSEcCtD
Thioridazine—Anorexia—Methotrexate—testicular cancer	0.000406	0.00146	CcSEcCtD
Thioridazine—Leukopenia—Doxorubicin—testicular cancer	0.000404	0.00146	CcSEcCtD
Thioridazine—Confusional state—Epirubicin—testicular cancer	0.000402	0.00145	CcSEcCtD
Thioridazine—Oedema—Epirubicin—testicular cancer	0.000398	0.00144	CcSEcCtD
Thioridazine—Hypotension—Methotrexate—testicular cancer	0.000398	0.00143	CcSEcCtD
Thioridazine—Thrombocytopenia—Epirubicin—testicular cancer	0.00039	0.00141	CcSEcCtD
Thioridazine—Tachycardia—Epirubicin—testicular cancer	0.000389	0.0014	CcSEcCtD
Thioridazine—Hyperhidrosis—Epirubicin—testicular cancer	0.000385	0.00139	CcSEcCtD
Thioridazine—Anorexia—Epirubicin—testicular cancer	0.00038	0.00137	CcSEcCtD
Thioridazine—Somnolence—Methotrexate—testicular cancer	0.000378	0.00136	CcSEcCtD
Thioridazine—Hypotension—Epirubicin—testicular cancer	0.000372	0.00134	CcSEcCtD
Thioridazine—Confusional state—Doxorubicin—testicular cancer	0.000372	0.00134	CcSEcCtD
Thioridazine—Decreased appetite—Methotrexate—testicular cancer	0.00037	0.00133	CcSEcCtD
Thioridazine—Oedema—Doxorubicin—testicular cancer	0.000369	0.00133	CcSEcCtD
Thioridazine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000361	0.0013	CcSEcCtD
Thioridazine—Tachycardia—Doxorubicin—testicular cancer	0.00036	0.0013	CcSEcCtD
Thioridazine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000356	0.00129	CcSEcCtD
Thioridazine—Somnolence—Epirubicin—testicular cancer	0.000354	0.00128	CcSEcCtD
Thioridazine—Anorexia—Doxorubicin—testicular cancer	0.000351	0.00127	CcSEcCtD
Thioridazine—Feeling abnormal—Methotrexate—testicular cancer	0.000351	0.00127	CcSEcCtD
Thioridazine—Decreased appetite—Epirubicin—testicular cancer	0.000346	0.00125	CcSEcCtD
Thioridazine—Hypotension—Doxorubicin—testicular cancer	0.000344	0.00124	CcSEcCtD
Thioridazine—Constipation—Epirubicin—testicular cancer	0.000341	0.00123	CcSEcCtD
Thioridazine—Body temperature increased—Methotrexate—testicular cancer	0.000336	0.00121	CcSEcCtD
Thioridazine—Feeling abnormal—Epirubicin—testicular cancer	0.000328	0.00118	CcSEcCtD
Thioridazine—Somnolence—Doxorubicin—testicular cancer	0.000328	0.00118	CcSEcCtD
Thioridazine—Decreased appetite—Doxorubicin—testicular cancer	0.00032	0.00116	CcSEcCtD
Thioridazine—Constipation—Doxorubicin—testicular cancer	0.000315	0.00114	CcSEcCtD
Thioridazine—Body temperature increased—Epirubicin—testicular cancer	0.000315	0.00114	CcSEcCtD
Thioridazine—Hypersensitivity—Methotrexate—testicular cancer	0.000314	0.00113	CcSEcCtD
Thioridazine—Feeling abnormal—Doxorubicin—testicular cancer	0.000304	0.0011	CcSEcCtD
Thioridazine—Hypersensitivity—Epirubicin—testicular cancer	0.000293	0.00106	CcSEcCtD
Thioridazine—Body temperature increased—Doxorubicin—testicular cancer	0.000291	0.00105	CcSEcCtD
Thioridazine—Diarrhoea—Methotrexate—testicular cancer	0.000291	0.00105	CcSEcCtD
Thioridazine—Diarrhoea—Epirubicin—testicular cancer	0.000272	0.000983	CcSEcCtD
Thioridazine—Hypersensitivity—Doxorubicin—testicular cancer	0.000271	0.000979	CcSEcCtD
Thioridazine—Vomiting—Methotrexate—testicular cancer	0.000271	0.000976	CcSEcCtD
Thioridazine—Rash—Methotrexate—testicular cancer	0.000268	0.000968	CcSEcCtD
Thioridazine—Dermatitis—Methotrexate—testicular cancer	0.000268	0.000967	CcSEcCtD
Thioridazine—Headache—Methotrexate—testicular cancer	0.000267	0.000962	CcSEcCtD
Thioridazine—Vomiting—Epirubicin—testicular cancer	0.000253	0.000913	CcSEcCtD
Thioridazine—Nausea—Methotrexate—testicular cancer	0.000253	0.000912	CcSEcCtD
Thioridazine—Diarrhoea—Doxorubicin—testicular cancer	0.000252	0.00091	CcSEcCtD
Thioridazine—Rash—Epirubicin—testicular cancer	0.000251	0.000906	CcSEcCtD
Thioridazine—Dermatitis—Epirubicin—testicular cancer	0.000251	0.000905	CcSEcCtD
Thioridazine—Headache—Epirubicin—testicular cancer	0.000249	0.0009	CcSEcCtD
Thioridazine—Nausea—Epirubicin—testicular cancer	0.000237	0.000853	CcSEcCtD
Thioridazine—Vomiting—Doxorubicin—testicular cancer	0.000234	0.000845	CcSEcCtD
Thioridazine—Rash—Doxorubicin—testicular cancer	0.000232	0.000838	CcSEcCtD
Thioridazine—Dermatitis—Doxorubicin—testicular cancer	0.000232	0.000837	CcSEcCtD
Thioridazine—Headache—Doxorubicin—testicular cancer	0.000231	0.000833	CcSEcCtD
Thioridazine—Nausea—Doxorubicin—testicular cancer	0.000219	0.00079	CcSEcCtD
